A carregar...
Inhibitors of mTOR
Inhibitors of mammalian target of rapamycin (mTOR) have been approved for the treatment of renal cell carcinoma and appear to have a role in the treatment of other malignancies. The primary objective of this drug review is to provide pharmacokinetic and dynamic properties of the commonly used drugs...
Na minha lista:
Main Authors: | , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
AlphaMed Press
2010
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3227930/ https://ncbi.nlm.nih.gov/pubmed/21147869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0196 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|